Report copyright - Financial view - Medicines for Malaria Venture · 2019. 6. 28. · Voucher (PRV) received by our pharmaceutical partner GlaxoSmithKline (GSK) upon approval of Krintafel (tafenoquine)
Please pass captcha verification before submit form